Literature DB >> 2538552

The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells.

J Bill1, O Kanagawa, D L Woodland, E Palmer.   

Abstract

We have generated an mAb, RR3-15, that recognizes murine TCRs containing the V beta 11 domain. Using this antibody to stain peripheral T cells, we have demonstrated that V beta 11-bearing T cells are largely absent from strains of mice that express the class II MHC molecule, I-E. Studies with F1 mice demonstrate that this effect is dominant, consistent with tolerance. The clonal deletion of V beta 11-bearing T cells appears to occur intrathymically, as immature but not mature V beta 11+ T cells are present in the thymus of I-E-bearing mice. Examination of B6 x DBA/2 recombinant inbred strains demonstrates that the expression of I-E molecules is necessary for the clonal deletion of V beta 11-bearing T cells, but that other non-MHC genes control the clonal deletion process, as well. Paradoxically, only a small fraction of V beta 11+ T cell hybridomas are I-E reactive.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538552      PMCID: PMC2189240          DOI: 10.1084/jem.169.4.1405

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity.

Authors:  J Yagüe; J White; C Coleclough; J Kappler; E Palmer; P Marrack
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Transfer of specificity by murine alpha and beta T-cell receptor genes.

Authors:  Z Dembić; W Haas; S Weiss; J McCubrey; H Kiefer; H von Boehmer; M Steinmetz
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

3.  Correlations between T-cell specificity and the structure of the antigen receptor.

Authors:  P J Fink; L A Matis; D L McElligott; M Bookman; S M Hedrick
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

4.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

5.  The T cell repertoire may be biased in favor of MHC recognition.

Authors:  M Blackman; J Yagüe; R Kubo; D Gay; C Coleclough; E Palmer; J Kappler; P Marrack
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

6.  T-cell antigen receptors with identical variable regions but different diversity and joining region gene segments have distinct specificities but cross-reactive idiotypes.

Authors:  F Rupp; J Brecher; M A Giedlin; T Mosmann; R M Zinkernagel; H Hengartner; R H Joho
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

8.  Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c.

Authors:  A Winoto; J L Urban; N C Lan; J Goverman; L Hood; D Hansburg
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

9.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Murine T-cell receptor mutants with deletions of beta-chain variable region genes.

Authors:  M A Behlke; H S Chou; K Huppi; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

View more
  106 in total

1.  Positive selection of Tcrb-V10b+ T cells.

Authors:  K Tomonari; R Hederer; H Hengartner
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.

Authors:  K Nishijima; T Hisatsune; H Kato; M Kohyama; M Kakehi; S Hachimura; S Kaminogawa
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

3.  The genetic basis of negative selection of Tcrb-V11+ T cells.

Authors:  K Tomonari; S Fairchild
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Identification of a mouse T-cell antigen receptor alpha-chain polymorphism by a V alpha 3.2 chain-specific monoclonal antibody.

Authors:  Y Utsunomiya; J Bill; E Palmer; O Kanagawa
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 5.  Significance of MHC class II haplotypes and IgG Fc receptors in SLE.

Authors:  Sachiko Hirose; Yi Jiang; Hiroyuki Nishimura; Toshikazu Shirai
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

6.  Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule.

Authors:  Y Itoh; K Kajino; K Ogasawara; A Takahashi; K Namba; I Negishi; N Matsuki; K Iwabuchi; M Kakinuma; R A Good; K Onoé
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

7.  Negative selection of Tcra-V8+CD8+ T cells by MHC class I molecules.

Authors:  K Tomonari
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.

Authors:  J J Ryan; H B LeJeune; J J Mond; F D Finkelman
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

9.  Co-segregation of a gene encoding a deletion ligand for Tcrb-V3+ T cells with Mtv-3.

Authors:  S Fairchild; A M Knight; P J Dyson; K Tomonari
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

10.  V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.

Authors:  Y X Zhao; U Brunsberg; R Holmdahl; A Tarkowski
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.